Reuters Health Report

Click to View in Browser 02/26/2014 Tiny Northwest Biotherapeutics aims to dominate brain cancer NEW YORK (Reuters) - Ten years ago, cash-strapped biotechnology company Northwest Biotherapeutics Inc was down to three employees and one week from closing its doors when a financial backer came forward at the annual JP Morgan Healthcare Conference. European politicians back tougher anti-tobacco rules BRUSSELS (Reuters) - EU politicians voted for a new anti-tobacco law on Wednesday that forces cigarette makers to increase the size of health warnings on packets and for the first time regulates electronic cigarettes. U.S. insurers say proposed Medicare cuts less than feared (Reuters) - U.S. health insurers including Humana Inc said on Monday that the government's proposed cuts to privately run Medicare programs appear to represent a funding decline of around 4 percent, less than the possible cuts of 7 percent or deeper that analysts had been expecting. FDA approves Bristol-Myers drug for rare body fat disorder (Reuters) - Bristol-Myers Squibb Co said the U.S. Food and Drug Administration approved its drug to treat rare and potentially fatal disorders involving loss of body fat. Prenatal acetaminophen exposure linked to ADHD risk NEW YORK (Reuters Health) - Children born to women who take acetaminophen during pregnancy may be at increased risk of attention deficit hyperactivity disorder (ADHD) and similar behavioral problems, new findings suggest. Receipts may be source of endocrine disruptor: study NEW YORK (Reuters Health) - Handling receipts may increase the body's level of a chemical that has been linked to reproductive and neurological problems, suggests a new small study. Popular U.S. health reform plan may not cut costs, boost quality: study CHICAGO (Reuters) - Increased attention given to patients in primary care practices organized into so-called medical homes may not improve quality of care or reduce health costs as reformers of the U.S. healthcare system had hoped, researchers said on Tuesday. Obesity rates remain high, but stable in the U.S NEW YORK (Reuters Health) - More than a third of U.S. adults and 17 percent of kids and teens are obese, rates that haven't changed much in a decade, researchers say. U.S. Medicare chief defends proposed Part D drug benefit reforms WASHINGTON (Reuters) - The Obama administration's top Medicare official on Tuesday defended proposed changes to the popular Part D drug benefits program for the elderly and disabled that are fiercely opposed by a broad network of drugmakers, insurers, healthcare providers and patient advocates. FDA approves Anika Therapeutics arthritis drug; shares soar (Reuters) - Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility in patients with osteoarthritis of the knee, more than four years after it first filed for approval. Related Video Ice jam on Pennsylvania river raises flooding fears Minnesota digs out from another winter storm The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend